Clinical Trial Update: Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating renal denervation in end-stage renal disease patients with refractory hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hypertension

Drugs mentioned

• Renal denervation device

Snippet

Sponsor: Medtronic Vascular | Conditions: Kidney Failure, Chronic, Renal Dialysis | Phase 1 | Status: COMPLETED